Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
21.48
-1.14 (-5.06%)
At close: Apr 28, 2026, 4:00 PM EDT
21.49
+0.01 (0.07%)
After-hours: Apr 28, 2026, 4:04 PM EDT

Lyell Immunopharma Market Cap

Lyell Immunopharma has a market cap or net worth of $500.98 million as of April 28, 2026. Its market cap has increased by 308.92% in one year.

Market Cap
500.98M
Enterprise Value
307.20M
1-Year Change
308.92%
Ranking
Category
Stock Price
$21.48

Market Cap Chart

Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $500.98M, a decrease of -87.86%. That is a compound annual growth rate of -35.19%.

History

DateMarket Cap% Change
Apr 27, 2026527.69M-19.30%
Dec 31, 2025653.89M249.70%
Dec 31, 2024186.98M-61.73%
Dec 29, 2023488.63M-43.52%
Dec 30, 2022865.16M-53.52%
Dec 31, 20211.86B-54.91%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Upstream Bio 516.45M
Zura Bio 515.20M
AgomAb Therapeutics NV 513.20M
Fulcrum Therapeutics 507.08M
MiMedx Group 499.93M
XOMA Royalty 497.24M
Valneva SE 485.14M
ADC Therapeutics 483.32M
Market Cap Rankings